A Discussion on 7-Ketocholesterol and Atherosclerosis at the December Journal Club

Journal Club December 7-Ketocholesterol & Atherosclerosis
In the December edition, hosted by Dr. Oliver Medvedik we welcome Dr. Matthew O’ Connor, formerly from SENS Research Foundation, and now head researcher at Underdog Pharma. This spin-off biotech is turning research done at SENS into a solution to heart disease.

Dr. O’Connor is going to give a brief presentation on 7-Ketocholesterol. This harmful byproduct from oxidized cholesterol, which Underdog believes can be a target for therapeutic intervention in order to prevent the formation artery plaques that are the basis of atherosclerosis. We will then review the paper his team published, and discuss it with questions and comments.


Leave a Reply

Your email address will not be published. Required fields are marked *